Ranking · Brussels · NACE 21

Manufacture of basic pharmaceutical products and pharmaceutical preparations: the largest employers in Brussels

As of 13 Nov 2026, 20 companies in Manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21) in Brussels report employees in recent accounts (financial years 2025 to 2026). The 10 largest employers account for 5,474.3 FTE, out of 5,626.9 for all of them; median headcount is 49.9 FTE. UCB Pharma leads with 1,960.6 FTE (financial year 2025).

Top 20 · Manufacture of basic pharmaceutical products and pharmaceutical preparations · Brussels

Ranked by average headcount (FTE) reported in the latest filed accounts (accounts less than 3 years old).

#Company Total assetsRevenue EquityFTEYear
1 UCB Pharma 1070 Anderlecht €20.7bn €4.62bn €16.2bn 1,960.6 2025
2 UCB Biopharma 1070 Anderlecht €7.15bn €2.04bn €1.18bn 1,395.2 2025
3 Novo Nordisk Production Belgium SA 1120 Brussels €153.5m €246.3m €74.2m 587.2 2025
4 PHOENIX Pharma Belgium 1200 Woluwe-Saint-Lambert €235.4m €1.33bn €46.5m 496.7 2026
5 Prothya Biosolutions Belgium 1120 Brussels €134.4m €109.1m −€2.24m 349.0 2026
6 Pfizer 1050 Ixelles €377.4m €358.3m €129.1m 297.0 2025
7 Roche 1070 Anderlecht €164.7m €448.8m €64.5m 122.7 2025
8 Besins Manufacturing Belgium 1050 Ixelles €19.1m €39.7m €7.92m 104.7 2025
9 Laboratoires Sterop 1070 Anderlecht €23.9m €17.3m €8.03m 101.5 2025
10 Boiron 1140 Evere €9.25m €12.2m €6.59m 59.7 2025
11 Laboratoires S.M.B. 1080 Molenbeek-Saint-Jean €261.5m €112.5m €172.9m 40.0 2025
12 Ipsen 1000 Brussels €134.4m €71.3m €119.9m 39.9 2025
13 Ferring 1070 Anderlecht €11.0m €20.4m €3.09m 13.8 2025
14 Departement Central de Fractionnement 1120 Brussels €19.7m €11.2m €18.7m 13.2 2025
15 Betaplus Pharma 1200 Woluwe-Saint-Lambert €24.9m €5.41m €22.3m 11.3 2025
16 A.forall Development 1070 Anderlecht €71.3m — €37.6m 10.9 2025
17 Alexion Pharma Belgium 1000 Brussels €8.68m €20.8m €3.44m 9.3 2025
18 bioprojet benelux 1080 Molenbeek-Saint-Jean 673,084 € — 346,087 € 5.8 2025
19 Laboratoires Sopreli 1070 Anderlecht €1.10m — 596,319 € 4.5 2025
20 Pharma MAR 1000 Brussels 492,662 € — 223,426 € 3.9 2025

Ranking based on each company's own annual accounts (statutory, not consolidated): a subsidiary and its parent appear separately, and the ranking differs from lists based on consolidated group accounts. Headcount reported by the company for all its sites: the jobs may be located elsewhere.

“—”: not published. Small companies (micro and abridged accounts) do not have to publish their revenue.

Manufacture of basic pharmaceutical products and pharmaceutical preparations across Belgium → All sectors · Brussels →

Other sectors · Brussels

Municipalities with the most companies in the sector · Brussels

Frequently asked questions

Which is the largest employer in Manufacture of basic pharmaceutical products and pharmaceutical preparations in Brussels?

Among companies, UCB Pharma, with 1,960.6 full-time equivalents reported (financial year 2025).

Are all the jobs located in the area?

Not necessarily: headcount is reported by the company for all its sites, and the company is ranked by the address of its registered office. 20 out of 83 companies in the sector report employees there.

Why does this ranking differ from other lists?

It uses each company's annual accounts as filed with the National Bank, not consolidated group accounts. A holding, a subsidiary or a purchasing entity can therefore appear separately. Only companies whose latest accounts are less than 3 years old are ranked.

Idonis

Analyse companies · Brussels

Filter these companies by size, soundness and trend, follow them and get an alert when their accounts or publications change.

Open the full file →
Free account in 30 seconds, by email. No bank card.

Active companies (legal entities) that have filed at least one set of annual accounts, based on the Crossroads Bank for Enterprises and the National Bank of Belgium. The sector is the main activity in the register; the municipality is that of the registered office. Data updated on 13 Nov 2026.